Mattia Boeri

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

Mattia Boeri, Carla Verri, Davide Conte et al. · Proceedings of the National Academy of Sciences · 2011 · 723 citations

Medicine, Molecular Biology, Oncology +17

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

Ugo Pastorino, Mario Silva, Stefano Sestini et al. · Annals of Oncology · 2019 · 519 citations · Full text

Medicine, Oncology, Preventive Medicine +10

Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study

Gabriella Sozzi, Mattia Boeri, Marta Rossi et al. · Journal of Clinical Oncology · 2014 · 437 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

Giuseppe Lo Russo, Massimo Moro, Michele Sommariva et al. · Clinical Cancer Research · 2018 · 407 citations · Full text

Medicine, Immunology, Oncology +17

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy

Giovanni Apolone, Emanuele Montomoli, Alessandro Manenti et al. · Tumori Journal · 2020 · 179 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +10